NEW YORK, April 01, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of INSYS Therapeutics, Inc. (“INSYS”) (NASDAQ:INSY) between March 3, 2015 and January 25, 2016.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of Arizona. If you purchased INSYS securities between March 3, 2015 and January 25, 2016, your rights may be affected by this action. To get more information go to: http://zlk.9nl.com/insys-therapeutics, or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that INSYS made materially false and misleading statements to investors and/or failed to disclose that: (i) the Company was engaged in the illegal and improper off-labeling marketing of Subsys, a cancer pain treatment; (ii) certain INSYS employees were complicit in an illegal kickback scheme operated for the purpose of increasing prescriptions of Subsys; and (iii) as a result, the Company’s financial statements were materially false and misleading at all relevant times.
On January 25, 2016, the Southern Investigating Report Foundation published an article entitled “The Brotherhood of Thieves: Insys Therapeutics,” alleging that INSYS pressured employees to develop new schemes to promote the illegal and inappropriate off-label use and sale of Subsys.
If you suffered a loss in INSYS you have until April 4, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


KKR's $820M Investment Fuels Samsung SDS AI Expansion, Sending Group Shares Soaring
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
CATL Stock Hits Record High After Q1 2025 Earnings Surge
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 



